VAERS Datenanalyse und Statistik
Zurueck zur Suche

Reporte zur Charge Y4NG3

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
1Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
1Bleibende Schaeden
MI 2 LA 1 OH 1 TX 1 IL 1 NJ 1 CA 1 CO 1

VAERS 2690534

GLAXOSMITHKLINE BIOLOGICALS · ROTAVIRUS (ROTARIX) · Charge Y4NG3

kritisch
Staat
LA
Alter
0,2
Geschlecht
F
Eingang
04.10.2023
Impfdatum
03.10.2023
Beginn
04.10.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
PO / MO
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Unresponsive to stimuli

Symptomtext

Notified by mother that patient was unresponsive and called ambulance. Resulted in deceased patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2726814

GLAXOSMITHKLINE BIOLOGICALS · ROTAVIRUS (ROTARIX) · Charge y4ng3

mild
Staat
OH
Alter
0,3
Geschlecht
M
Eingang
22.12.2023
Impfdatum
20.12.2023
Beginn
21.12.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Vomiting

Symptomtext

Pt had a developed rash and started vomiting and unable to keep breast milk or formula down

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
no
Allergien
no
Vorherige Impfungen
-

VAERS 2713193

GLAXOSMITHKLINE BIOLOGICALS · ROTAVIRUS (ROTARIX) · Charge Y4NG3

mild
Staat
MI
Alter
0,1
Geschlecht
F
Eingang
13.11.2023
Impfdatum
31.10.2023
Beginn
06.11.2023
Tage bis Beginn
6,0
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: ja
Anuria Barium enema Haematochezia Infant irritability Intussusception Large intestinal obstruction reduction Pain Poor feeding infant Procedural failure Small intestinal intussusception reduction X-ray

Symptomtext

Onset of symptoms on 11/6/23 at approximately 2200: not wanting to nurse, irritable, not making wet diapers in over 4 hours, one bloody stool, appeared to be in pain. Advised to go to the ER. Went to ER. Diagnosed with Intussusception and transferred to another hospital. IV hydration and non-surgical reduction attempted with barium enema, but unsuccessful. Surgical reduction with removal of right lower colon and part of the small intestines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
5,0
Labordaten
11/6/2023 xrays 11/6/2023 abdominal surgery
Aktuelle Erkrankungen
Nasal congestion 10/10/2023.
Vorgeschichte
40 weeks, 1 day gestational age, normal vaginal delivery. Mom GBS + and treated with prophylaxis.
Andere Medikamente
Hydrocortisone 1% ointment Nystatin cream The following vaccines given along with the Rotarix on 10/31/2023: Prevnar 20 Lot # GY1932; NDC 0005-2000-04; EXP 12/31/2024 HIB Lot # X005171; NDC 0006-4897-01; EXP 11/13/2025 Pediarix Lot # A32BB;
Allergien
None
Vorherige Impfungen
-

VAERS 2723267

GLAXOSMITHKLINE BIOLOGICALS · ROTAVIRUS (ROTARIX) · Charge Y4NG3

gering
Staat
TX
Alter
0,2
Geschlecht
M
Eingang
12.12.2023
Impfdatum
07.12.2023
Beginn
07.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

ask pt to wait 15 min after vaccine saw no reaction after 15 min given vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
BEYFORTUS
Allergien
-
Vorherige Impfungen
-

VAERS 2714324

GLAXOSMITHKLINE BIOLOGICALS · ROTAVIRUS (ROTARIX) · Charge Y4NG3

gering
Staat
IL
Alter
0,2
Geschlecht
F
Eingang
15.11.2023
Impfdatum
15.11.2023
Beginn
15.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation error Single component of a two-component product administered

Symptomtext

I was asked by CMA to assist with pediatric vaccines as she has never given VFC vaccines before. I verified the orders and then went to the medication room where CMA already had the vaccines laid out. I assisted her with scanning and order entry for the vaccines. Vaccines were given to pt. I advised CMA that we needed to correct the Rotarix order so that she could document the Rotarix as I had forgotten to scan the box instead of the vial since the vaccine needed to be mixed. We do have both the premixed Rotarix and the powder vaccine that needs to be reconstituted with the accompanying diluent. Immediately after scanning the syringe that CMA had out, I noticed that she hadn't gotten out the powder vial that goes along with it. I retrieved the vial as I was explaining to CMA that the two get mixed together to make the vaccine that was to be given. The two were mixed together prior to being given to the pt. It was upon scanning the box for the 2 part Rotarix vaccine that I realized that the syringe that CMA pulled was from the new premixed vaccine box as the lot number was different. As the VFC coordinator, I had checked inventory levels of VFC vaccines just prior to this occurrence. At that time, the premixed Rotarix had not yet been opened so it did not occur to me to double check the syringe myself in case the premixed box of vaccines had been opened and the syringe pulled from it. Dr was made aware per myself. The inpatient pharmacy was contacted and staff advised that the parents should be made aware that vomiting, diarrhea and fussiness are to be watched for. The mother verbalized understanding and was agreeable to taking the pt to the ER should any bad side effects occur. I will contact the mother in the am to check on the pt myself. VAERS reporting is being completed as well as a note in the pt's chart. Pt has yet to experience any adverse effects as this moment in time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
GERD
Andere Medikamente
famotidine 40mg/5mL 0.3 mls by mouth at bedtime x 4 weeks. Started 11/2/23
Allergien
NKA
Vorherige Impfungen
-

VAERS 2713708

GLAXOSMITHKLINE BIOLOGICALS · ROTAVIRUS (ROTARIX) · Charge Y4NG3

gering
Staat
MI
Alter
0,2
Geschlecht
F
Eingang
14.11.2023
Impfdatum
13.11.2023
Beginn
13.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Wrong product administered

Symptomtext

IPV given instead of Prevnair13. Patient also received vaxelis which also contains IPV

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
na
Vorgeschichte
na
Andere Medikamente
na
Allergien
na
Vorherige Impfungen
-

VAERS 2709487

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge Y4NG3

gering
Staat
NJ
Alter
0,3
Geschlecht
F
Eingang
03.11.2023
Impfdatum
03.11.2023
Beginn
03.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Child did not experience an adverse effect , she was accidently given the flu shot. Nurse realized the mistake after administration and the DR was quickly made aware. DR spoke to the parent and the baby was fine before leaving the clinic .

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
no
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
no
Allergien
no
Vorherige Impfungen
-

VAERS 2695825

GLAXOSMITHKLINE BIOLOGICALS · ROTAVIRUS (ROTARIX) · Charge Y4NG3

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
13.10.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Intercepted product storage error Product temperature excursion issue

Symptomtext

Product temperature excursion issue; This non-serious case was reported by a other health professional and described the occurrence of intercepted product storage error in a patient who received DTPa (Infanrix) (batch number A5573, expiry date 13-JUL-2025) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) (batch number A32BB, expiry date 10-AUG-2025) for prophylaxis, DTPa-IPV (Kinrix) (batch number 7D2Y4, expiry date 22-AUG-2025) for prophylaxis, HAV (Havrix) (batch number 2YS34, expiry date 02-MAR-2025) for prophylaxis, HBV (Engerix B) (batch number EP724, expiry date 14-MAR-2025) for prophylaxis, Hib (Hiberix) (batch number G3453, expiry date 12-NOV-2024) for prophylaxis, Men ACWY-CRM NVS (Menveo) (batch number 9C2KP, expiry date 31-DEC-2024) for prophylaxis, Men B NVS (Bexsero) (batch number 2X955, expiry date 31-JAN-2026) for prophylaxis and Rota (Rotarix lyophilized formulation) (batch number Y4NG3, expiry date 03-OCT-2025) for prophylaxis. On an unknown date, the patient did not receive Infanrix .5 ml, Pediarix .5 ml, Kinrix .5 ml, Havrix .5 ml, Engerix B .5 ml, Hiberix .5 ml, Menveo .5 ml, Bexsero .5 ml and Rotarix lyophilized formulation .5 ml. On an unknown date, an unknown time after receiving Infanrix, Pediarix, Kinrix, Havrix, Engerix B, Hiberix, Menveo, Bexsero and Rotarix lyophilized formulation, the patient experienced intercepted product storage error (Verbatim: Product temperature excursion issue). The outcome of the intercepted product storage error was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 4-Oct-2023 The pharmacy technician reaching out to GlaxoSmithKline to inquired about a temperature excursion and to verify validation of stability. There were several GlaxoSmithKline vaccines that were affected. Excursion started on 30th September 2023 at 7:21 pm 8.0 C thru 1st October 2023 11:55 pm reaching 28.5C. The several GlaxoSmithKline vaccines had temperature excursion and all medications had been removed to recommended storage and quarantined, which led to intercepted product storage error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intercepted product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2692350

GLAXOSMITHKLINE BIOLOGICALS · ROTAVIRUS (ROTARIX) · Charge Y4NG3

gering
Staat
CO
Alter
0,2
Geschlecht
F
Eingang
06.10.2023
Impfdatum
06.10.2023
Beginn
06.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Swelling of eyelid

Symptomtext

Patient received Beyfortus (RSV mAb nirsevimab, 0.5mL) LOT: 2022829 in the Left thigh at 0900. Mother called post visit at 1600 and states she noticed eyelid swelling at 1500. No other symptoms reported. Mother was advised to have patient seen in urgent care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Swelling of eyelid
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Unknown
Vorherige Impfungen
-